Cornelis Arjan Van Oeveren

This inventor holds 22 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignee: Ligand Pharmaceuticals, Inc.. Active years: 2003-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cornelis Arjan Van Oeveren. Retrieved from https://idiyas.com/inventor/cornelis-arjan-van-oeveren

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 1)

% Patents Active = 72.7

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 5.1

ph-index = 7

Forward Citations = 155(Granted Patents)

Location History:

Carlsbad, CA (US) (2006 - 2007)
San Diego, CA (US) (2003 - 2023)

Company Filing History:

22 out of 139

Ligand Pharmaceuticals, Inc.

patents

Years Active: 2003-2023

Loading Chart...

Areas of Expertise:

Heterocycle Amines

Androgen Receptor Modulators

Hematopoietic Growth Factors

Small Molecule Compounds

Granulocyte Colony-Stimulating Factor

Tricyclic Compounds

Bicyclic Compounds

Selective Modulators

Progesterone Receptor

Methods and Compositions

Growth Factor Mimetic

Pharmaceutical Applications

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11773110 - Heterocycle amines and uses thereof (2023-10-03),

2. 11413274 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor (2022-08-16),

3. 11186593 - Heterocycle amines and uses thereof (2021-11-30),

4. 10736875 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor (2020-08-11),

5. 10604533 - Heterocycle amines and uses thereof (2020-03-31),

6. 10030034 - Heterocycle amines and uses thereof (2018-07-24),

7. 9622991 - Hematopoietic growth factor mimetic small molecule compounds and their uses (2017-04-18),

8. 9359285 - Androgen receptor modulator compounds and methods (2016-06-07),

9. 9266874 - Heterocycle amines and uses thereof (2016-02-23),

10. 9144557 - Hematopoietic growth factor mimetic small molecule compounds and their uses (2015-09-29),

11. 8865918 - Androgen receptor modulator compounds and methods (2014-10-21),

12. 8680150 - Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors (2014-03-25),

13. 8580811 - Androgen receptor modulator methods (2013-11-12),

14. 8519158 - Androgen receptor modulator compounds and methods (2013-08-27),

15. 8193357 - Androgen receptor modulator compounds (2012-06-05),

Title: The Innovative Journey of Inventor Cornelis Arjan van Oeveren

Introduction: Cornelis Arjan van Oeveren, a talented inventor based in San Diego, CA (US), has made significant contributions to the field of technology with his groundbreaking inventions.

Latest Patents: Van Oeveren holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices. His most recent patent focuses on a revolutionary method for enhancing solar panel efficiency through nanotechnology.

Career Highlights: With a background in engineering and a passion for innovation, Van Oeveren has enjoyed a successful career marked by numerous achievements. He has worked for leading tech companies, where he has spearheaded projects that have pushed the boundaries of what is possible in the industry.

Collaborations: Known for his collaborative spirit, Van Oeveren has partnered with top researchers, engineers, and scientists to bring his ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many of his projects.

Conclusion: In conclusion, Cornelis Arjan van Oeveren stands out as a visionary inventor who continues to drive technological advancements through his creativity and dedication. His innovative spirit and commitment to excellence make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.